SCYNEXIS, Inc. (SCYX)

SCYNEXIS, Inc. (SCYX) Company Bio

SCYNEXIS, Inc., a pharmaceutical company, develops and commercializes novel anti-infectives to address unmet therapeutic needs. Its lead product candidate includes SCY-078, which is in Phase I clinical trials of the intravenous formulation; Phase II clinical trials for the treatment of invasive candida infections; and Phase II clinical trials for unmet medical needs, such as vulvovaginal candidiasis. The company was founded in 1999 and is based in Jersey City, New Jersey.

$1.38 0.01 (0.73%)
Quote Time: Feb 15 4:00pm

$1.38
0.01 (0.73%)
Quote Time: Feb 15 4:00pm

Ranked of 201 in Medical - Pharmaceuticals

SCYX Daily Price Range

SCYX 52-Week Price Range

Add SCYX to Watchlist
Sign Up

SCYX - Live POWR Rating™

Overall POWR Rating

To view SCYX's real-time POWR Rating, sign up now.

Access Ratings for Free

SCYX - POWR Components

Learn More About POWR Ratings

SCYX News Stream

Event/Time	News Detail	Start	End	Change
Loading, please wait...

View All SCYX News

SCYX Stock Chart More Charts

SCYX Price/Volume Stats

Current price	$1.38
Prev. close	$1.37
Day low	$1.34
Day high	$1.40
50-day MA	$0.76
200-day MA	$1.21
52-week high	$2.15
52-week low	$0.35
Volume	494,259
Avg. volume	1,864,053
Dividend yield	N/A
Market Cap	66.20M

SCYX Social Stream

View Full SCYX Social Stream

SCYX Returns

1-mo	72.50%
3-mo	70.37%
6-mo	0.73%
1-year	-22.03%
3-year	-70.76%
5-year	N/A

YTD	187.50%
2018	-79.31%
2017	-27.27%
2016	-48.63%
2015	-37.78%
2014	N/A

SCYNEXIS, Inc. (SCYX)